Incidental Prostate Adenocarcinoma in Prostate Transurethral Resections: Our Eight Year Experience

Objective: Incidental early-stage prostate cancer (PC) can be detected in patients undergoing transurethral resection of the prostate (TURP) due to benign prostatic hyperplasia (BPH). In our study, we investigated the incidence of incidental PC and the relationship of the incidence of PC with age, serum prostate specific antigen (PSA) levels and resected prostate tissue volume in patients undergoing TURP for BPH. Materials and Methods: A total of 391 patients, who underwent TURP for BPH in our hospital between 2011 and 2018, were included in the study. Age and volumes of resection materials of the cases were obtained from pathology reports and blood PSA levels were obtained from the urology clinic. Results: In our series, incidental PC was detected in 17 of 391 cases (4.3%). The mean age of the patients with and without tumor was 74.5 years 69.5 years, respectively. The mean preoperative PSA level was 5.05 ng/mL in 226 patients without PC and the mean preoperative PSA level was 4.46 ng/mL in 15 patients with PC whose preoperative PSA levels could be checked by the urology clinic. Conclusion: In our study, incidental PC detection rate (

Prostat Transüretral Rezeksiyonlarında Rastlantısal Prostat Adenokarsinomu: Sekiz Yıllık Deneyimimiz

Amaç: Rastlantısal erken evre prostat kanseri (PK), benign prostat hiperplazisi (BPH) nedeniyle transüretral prostat rezeksiyonu (TURP) yapılan hastalarda tespit edilebilir. Çalışmamızda hastanemizde BPH nedeniyle TURP uygulanan hastalarda rastlantısal PK insidansı ve yaş, rezeke prostat dokusu hacmi ve serum prostat spesifik antijen (PSA) düzeyleri arasındaki ilişkiyi araştırdık. Gereç ve Yöntem: Çalışmamıza 2011 ve 2018 yılları arasında hastanemizde BPH nedeniyle TURP uygulanan 391 hasta dahil edildi. Olguların yaş ve TURP hacimleri patoloji raporlarından, serum PSA düzeyleri üroloji kliniğinden elde edildi. Bulgular: Serimizdeki 391 olgunun 17’sinde (%4,3) rastlantısal PK tespit edildi. Tümörü olan hastaların yaş ortalaması 74,5, tümörü olmayanların yaş ortalaması 69,5 idi. Preoperatif PSA düzeyleri 226 hastada ortalama 5.05 ng/mL iken, PK’li 15 hastada ortalama PSA düzeyi 4.46 ng/mL idi. Sonuç: Çalışmamızda BPH için TURP materyallerinde rastlantısal PK saptama oranı (

Kaynakça

Trpkov K, Thompson J, Kulaga A, Yilmaz A. How much tissue sampling is required when unsuspected minimal prostate carcinoma is identified on transurethral resection? Arch Pathol Lab Med 2008;132:1313-1316.

Varghese J, Kuruvilla PM, Mehta N, Rathore RS, Babu M, Bansal D, Pillai B, Sam MP, Krishnamorthy H. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India. AsianPac J Cancer Prev 2016;17:2255-2258.

U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999- 2011. Incidence and mortality web-based report. Atlanta, GA: Department of Health and Human Services, 2014.

OECD/European Union. Mortality from cancer. Health at a glance: Europe 2014. Paris: OECD Publishing, 2014.

Bozlu M. Prostat biyopsilerinin klinik yorumu. Üroonkoloji Bülteni 2007;2:8- 11.

Bell KJ, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. Int J Cancer 2015;137:1749-1757.

Lee DH, Chung DY, Lee KS, Kim IK, Rha KH, Choi YD, Chung BH, Hong SJ, Kim JH. Clinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: a study of a Korean high volume center. Yonsei Med J 2014;55:78-83.

Otto B, Barbieri C, Lee R, Te AE, Kaplan SA, Robinson B, Chughtai B. Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era. Adv Urol 2014;2014:627290.

Capogrosso P, Capitanio U, Vertosick EA, Ventimiglia E2, Chierigo F, Oreggia D, Moretti D, Briganti A, Vickers AJ, Montorsi F, Salonia A. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia. Urology 2018;122:152-157.

Fındık Güvendi G, Toyran T, Bağcıoğlu M, Kılıç Ö, Adalı Y. The Incidence and Significance of Incidental Prostate Carcinoma in Transurethral Resection (TUR-P) Materials between 2014 and 2016 at Our Center. Medical Sciences (NWSAMS), 2018;13:19-22.

WHO Classification of Tumours Editorial Board. World Health Organization (WHO) Classification of Tumors of the Urinary System and Male Genital Organs 2016, 4th ed.

Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwinw E. Prostatespecific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909.

Karabulut YY, Dölek Y, Özdemir Ü, Kurşun N. Documentation of Prostat Tur Materials in Cankırı Population: 133 Cases. Smyrna Tıp Dergisi.

Jones JS, Follis HW, Johnson JR. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis 2009;12:57-60.

Leite KR, Srougi M, Dall’Oglio MF, Sanudo A, Camara-Lopes LH. Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL. Int Braz J Urol 2008;34:283-290; discussion 290-292.

Bollito E, Terrone C, Volpe A, Porpiglia F, Cracco C, Poggio M, Grande S, Righi L, Bellina M, Papotti M, Scarpa RM. Changes in prostate cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience. Anal Quant Cytol Histol 2008 Jun;30:152-159.

Collage of American Pathologists (CAP). Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland. 2017.

Patoloji Dernekleri Federasyonu, Üropatoloji Çalışma Grubu. Ürolojik Tümörlerin Patolojik Değerlendirme Standartları ve Kılavuzları. 2010.

Adolfsson J. The management of category T1a-T1b (incidental) prostate cancer: can we predict who needs treatment? Eur Urol 2008;54:16-18.

Kaynak Göster

500 167

Arşiv
Sayıdaki Diğer Makaleler

Clinical Risk Factors for Extended Spectrum B-lactamase-producing Bacteriuria in Children with Myelodysplasia Performing Clean Intermittent Catheterization

Tuncay TOPRAK, Ahmet ŞAHAN, Muhammed SULUKAYA, Asgar GARAYEV, Çağrı Akın ŞEKERCİ, YILÖREN TANIDIR, Cem AKBAL, Tufan TARCAN

Laparoscopic Pyeloplasty, Our Experience of Initial Fifty Two Cases

Lokesh SHARMA, Nisar AHMED, Mahakshit BHAT, Aayush KHETRAPAL, Rajeev MATHUR, Ram Gopal YADAV

Incidental Prostate Adenocarcinoma in Prostate Transurethral Resections: Our Eight Year Experience

Hatice Ceren SAYAR, Sümeyye EKMEKÇİ, Özgür ÇAKMAK, Ülkü KÜÇÜK

Significance of Core Length in Current Transrectal Ultrasound-guided Prostate Biopsy in Patients with Normal Digital Rectal Examination

Mesut ALTAN, Burak ÇITAMAK, Emin MAMMADOV, NAİME MERİÇ KONAR, Bülent AKDOĞAN, Haluk ÖZEN

Granular Cell Tumors of the Urinary Bladder: An Extremely Rare Entity and Literature Review

İsmail EVREN, Osman ÖZDEMİR, Yunus ÇOLAKOĞLU, Nurten SEVER, Ali İhsan TAŞÇI

Predictive Factors for Postoperative Decline in Renal Functions Following Partial Nephrectomy: Preliminary Results

İsmail SELVİ, Halil BAŞAR

Risk Factors for Postoperative Urinary Retention in Surgical Population: A Prospective Cohort Study

Meltem ÇAKMAK, Murside YILDIZ, İlker AKARKEN, Yücel KARAMAN, Özgür ÇAKMAK

Are Haematological Parameters Reliable for Differential Diagnosis of Testicular Torsion and Epididymitis?

Reha GİRGİN, Önder ÇINAR, N. Aydın MUNGAN

Is Bacterial Colonization in Ureteral Double-J Stents Significant and Is It Predictable?

Ahmet ŞAHAN, Alkan ÇUBUK, Kasım ERTAŞ, Asgar GARAYEV, Ferhat TALİBZADE, Çağrı Akın ŞEKERCİ, Tuncay TOPRAK, YILÖREN TANIDIR

Comparison of 99mTc-DMSA, 99mTc-DTPA and 99mTc-MAG3 Renal Scintigraphy in the Calculation of Relative Renal Function

Fadime DEMİR, Mustafa DEMİR